SEC Form 4 · accession 0001209191-17-009613
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Md Carlo A Waldemar
Director
Period of report
Feb 9, 2017
Accepted (ET)
Feb 10, 2017 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2017 | M | 5,334 | $32.325 | A | 16,589 | D | |
| Common StockF1 | Feb 9, 2017 | S | 5,334 | $67.9014 | D | 11,255 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $32.325 | Feb 9, 2017 | M | 5,334 | D | Nov 1, 2010 | Nov 1, 2017 | Common Stock | 5,334 | 0 | D |
Explanation of responses
- F1Sales of shares were made in seventeen (17) separate transactions with prices ranging from $67.83 to $68.00 for a weighted average sales price of $67.9014.